Invention Grant
- Patent Title: Engineered HCV E2 immunogens and related vaccine compositions
-
Application No.: US16938105Application Date: 2020-07-24
-
Publication No.: US11008368B2Publication Date: 2021-05-18
- Inventor: Linling He , Jiang Zhu , Erick Giang , Mansun Law , Ian Wilson , Netanel Tzarum
- Applicant: THE SCRIPPS RESEARCH INSTITUTE
- Applicant Address: US CA La Jolla
- Assignee: THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee: THE SCRIPPS RESEARCH INSTITUTE
- Current Assignee Address: US CA La Jolla
- Agent Hugh Wang; Thomas Fitting
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N7/00 ; A61K39/29 ; A61K47/69 ; A61P31/14
Abstract:
The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.
Public/Granted literature
- US20210024585A1 Engineered HCV E2 Immunogens and Related Vaccine Compositions Public/Granted day:2021-01-28
Information query
